Science Explorer Back to mapMap
Discussion

Medpace (United States)

In research, Medpace (United States) stands highest in Physical Sciences (#8,111 of 17,446 worldwide), over all time.

World rank, 2022-now
#20,975
of 22,385 · #12,211 all time
Rank in United States
#3,104
of 3,332
Research works
286
▲ 29% vs 2018-21
Citations
5.6k
19.6 per fractional work
Top-10% rate
14.1%
all institutions 10.0%
vs its own fields
0.97×
1.00× is exactly expected
Open access
42%
world 40%
International
20%
world 18%

What is Medpace (United States) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Physical SciencesDomain #8,111 of 17,446 8.2%125

Each strip is that field's whole ranked pool, with the notch where Medpace (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Medpace (United States) work in?

In 2022-now, 51% of research at Medpace (United States) is in Health Sciences, 22% in Life Sciences. Its largest fields are Medicine (48%), Biochemistry, Genetics and Molecular Biology (15%), Engineering (6%). It does 2.0× the world's share of Health Sciences.

Health Sciences: 34 fractional works · 50.5% of its workMedicine: 32 fractional works · 48.2% of its workOncology: 7 fractional works · 10.3% of its workSurgery: 4 fractional works · 6.6% of its workEndocrinology, Diabetes and Metabolism: 4 fractional works · 5.7% of its workPulmonary and Respiratory Medicine: 3 fractional works · 4.0% of its workPhysiology: 2 fractional works · 2.7% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 2.1% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 1.8% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 1.6% of its workPathology and Forensic Medicine: 1 fractional works · 1.4% of its workEmergency Medicine: 1 fractional works · 1.4% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 1.4% of its workEpidemiology: 1 fractional works · 1.3% of its workPsychiatry and Mental health: 1 fractional works · 1.1% of its workHematology: 1 fractional works · 1.0% of its workRheumatology: 1 fractional works · 0.9% of its workGenetics: 0 fractional works · 0.7% of its workNeurology: 0 fractional works · 0.7% of its workInfectious Diseases: 0 fractional works · 0.6% of its workGeriatrics and Gerontology: 0 fractional works · 0.4% of its workPharmacology: 0 fractional works · 0.4% of its workComplementary and alternative medicine: 0 fractional works · 0.3% of its workOtorhinolaryngology: 0 fractional works · 0.3% of its workOrthopedics and Sports Medicine: 0 fractional works · 0.3% of its workRehabilitation: 0 fractional works · 0.2% of its workGastroenterology: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.8% of its workHealth Professions: 1 fractional works · 2.1% of its workGeneral Health Professions: 1 fractional works · 1.2% of its workSpeech and Hearing: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.2% of its workDentistry: 0 fractional works · 0.2% of its workNursing: 0 fractional works · 0.1% of its workLife Sciences: 15 fractional works · 22.1% of its workBiochemistry, Genetics and Molecular Biology: 10 fractional works · 15.0% of its workMolecular Biology: 5 fractional works · 8.1% of its workCancer Research: 2 fractional works · 3.1% of its workGenetics: 1 fractional works · 2.2% of its workBiotechnology: 0 fractional works · 0.5% of its workCell Biology: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.6% of its workNeuroscience: 2 fractional works · 3.6% of its workCognitive Neuroscience: 1 fractional works · 2.0% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.6% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.5% of its workBiological Psychiatry: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workImmunology and Microbiology: 2 fractional works · 3.1% of its workImmunology: 2 fractional works · 3.1% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 0 fractional works · 0.1% of its workPhysical Sciences: 10 fractional works · 15.3% of its workEngineering: 4 fractional works · 6.1% of its workElectrical and Electronic Engineering: 1 fractional works · 1.9% of its workBiomedical Engineering: 1 fractional works · 1.2% of its workAutomotive Engineering: 1 fractional works · 0.9% of its workControl and Systems Engineering: 1 fractional works · 0.8% of its workMedia Technology: 0 fractional works · 0.5% of its workAerospace Engineering: 0 fractional works · 0.3% of its workBuilding and Construction: 0 fractional works · 0.3% of its workSafety, Risk, Reliability and Quality: 0 fractional works · 0.3% of its workComputer Science: 2 fractional works · 3.3% of its workComputer Vision and Pattern Recognition: 1 fractional works · 1.3% of its workComputational Theory and Mathematics: 0 fractional works · 0.7% of its workArtificial Intelligence: 0 fractional works · 0.5% of its workInformation Systems: 0 fractional works · 0.3% of its workHardware and Architecture: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workMathematics: 2 fractional works · 2.8% of its workStatistics and Probability: 2 fractional works · 2.6% of its workApplied Mathematics: 0 fractional works · 0.3% of its workEnvironmental Science: 1 fractional works · 1.1% of its workEnvironmental Chemistry: 0 fractional works · 0.4% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.3% of its workEnvironmental Engineering: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMaterials Science: 1 fractional works · 0.8% of its workMaterials Chemistry: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.1% of its workChemistry: 0 fractional works · 0.7% of its workOrganic Chemistry: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysics and Astronomy: 0 fractional works · 0.3% of its workEarth and Planetary Sciences: 0 fractional works · 0.1% of its workEnergy: 0 fractional works · 0.1% of its workSocial Sciences: 8 fractional works · 12.1% of its workPsychology: 4 fractional works · 5.3% of its workSocial Psychology: 1 fractional works · 1.9% of its workExperimental and Cognitive Psychology: 1 fractional works · 1.2% of its workClinical Psychology: 1 fractional works · 0.9% of its workDevelopmental and Educational Psychology: 1 fractional works · 0.9% of its workApplied Psychology: 0 fractional works · 0.4% of its workSocial Sciences: 2 fractional works · 3.2% of its workSociology and Political Science: 2 fractional works · 2.4% of its workPolitical Science and International Relations: 0 fractional works · 0.3% of its workTransportation: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workEconomics, Econometrics and Finance: 1 fractional works · 1.6% of its workEconomics and Econometrics: 1 fractional works · 1.6% of its workDecision Sciences: 1 fractional works · 1.0% of its workStatistics, Probability and Uncertainty: 0 fractional works · 0.5% of its workInformation Systems and Management: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workArts and Humanities: 0 fractional works · 0.6% of its workPhilosophy: 0 fractional works · 0.3% of its workLiterature and Literary Theory: 0 fractional works · 0.3% of its workBusiness, Management and Accounting: 0 fractional works · 0.4% of its workALL ITS WORKMedpace (UnitedStates)67fractional works, 2022-now
Life Sciences22%Physical Sciences15%Health Sciences51%Social Sciences12%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 24 fields, with their numbers
    1. Medicine3248.2%
    2. Health Professions12.1%
    3. Dentistry00.2%
    4. Nursing00.1%
    1. Biochemistry, Genetics and Molecular Biology1015.0%
    2. Neuroscience23.6%
    3. Immunology and Microbiology23.1%
    4. Pharmacology, Toxicology and Pharmaceutics00.2%
    5. Agricultural and Biological Sciences00.1%
    1. Engineering46.1%
    2. Computer Science23.3%
    3. Mathematics22.8%
    4. Environmental Science11.1%
    5. Materials Science10.8%
    6. Chemistry00.7%
    7. Physics and Astronomy00.3%
    8. Earth and Planetary Sciences00.1%
    9. Energy00.1%
    1. Psychology45.3%
    2. Social Sciences23.2%
    3. Economics, Econometrics and Finance11.6%
    4. Decision Sciences11.0%
    5. Arts and Humanities00.6%
    6. Business, Management and Accounting00.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.03× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.81× its world share, 10 worksBiochemistry, Geneti…Immunology and Microbiology: 3.12× its world share, 2 worksImmunology and Micro…Neuroscience: 2.24× its world share, 2 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.61× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.44× its world share, 0 worksChemistryComputer Science: 0.42× its world share, 2 worksComputer ScienceEarth and Planetary Sciences: 0.05× its world share, 0 worksEarth and Planetary …Energy: 0.08× its world share, 0 worksEnergyEngineering: 0.41× its world share, 4 worksEngineeringEnvironmental Science: 0.23× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.23× its world share, 0 worksMaterials ScienceMathematics: 2.41× its world share, 2 worksMathematicsPhysics and Astronomy: 0.12× its world share, 0 worksPhysics and AstronomyDentistry: 0.44× its world share, 0 worksDentistryHealth Professions: 0.78× its world share, 1 worksHealth ProfessionsMedicine: 2.51× its world share, 32 worksMedicineNursing: 0.17× its world share, 0 worksNursingArts and Humanities: 0.20× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.11× its world share, 0 worksBusiness, Management…Decision Sciences: 1.06× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 0.76× its world share, 1 worksEconomics, Econometr…Psychology: 1.74× its world share, 4 worksPsychologySocial Sciences: 0.25× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 3.1×. Every wedge is a field page.

All 24 fields, with their numbers
  1. Immunology and Microbiology3.12×2 works
  2. Biochemistry, Genetics and Molecular Biology2.81×10 works
  3. Medicine2.51×32 works
  4. Mathematics2.41×2 works
  5. Neuroscience2.24×2 works
  6. Psychology1.74×4 works
  7. Decision Sciences1.06×1 works
  8. Health Professions0.78×1 works
  9. Economics, Econometrics and Finance0.76×1 works
  10. Pharmacology, Toxicology and Pharmaceutics0.61×0 works
  11. Chemistry0.44×0 works
  12. Dentistry0.44×0 works
  13. Computer Science0.42×2 works
  14. Engineering0.41×4 works
  15. Social Sciences0.25×2 works
  16. Environmental Science0.23×1 works
  17. Materials Science0.23×0 works
  18. Arts and Humanities0.20×0 works
  19. Nursing0.17×0 works
  20. Physics and Astronomy0.12×0 works
  21. Business, Management and Accounting0.11×0 works
  22. Energy0.08×0 works
  23. Earth and Planetary Sciences0.05×0 works
  24. Agricultural and Biological Sciences0.03×0 works

Who are the top researchers at Medpace (United States)?

Ranked on the quality score, Traci A. Turner, David G. Orloff and Douglas K. Logan lead among researchers whose main affiliation is Medpace (United States).

  1. 1 Traci A. Turner United States · #546,160 worldwide 4k citations · 54 works
  2. 2 David G. Orloff United States · #807,903 worldwide 1.9k citations · 34 works
  3. 3 Douglas K. Logan United States · #971,085 worldwide 1.3k citations · 21 works
  4. 4 Daniel Schlauch United States · #1,287,533 worldwide 1.1k citations · 33 works
  5. 5 Venkata Arun Timmaraju United States · #1,621,162 worldwide 232 citations · 15 works
  6. 6 Alidad Mireskandari United States · #1,732,765 worldwide 417 citations · 17 works
  7. 7 Gyanendra Kumar United States · #1,997,655 worldwide 307 citations · 20 works
  8. 8 Bradley Hammerson United States · #2,367,483 worldwide 196 citations · 13 works
  9. 9 Nicole A. Toney United States · #2,431,338 worldwide 425 citations · 37 works
  10. 10 Christina M. Narick United States · #2,483,848 worldwide 444 citations · 21 works
All ranked researchers at Medpace (United States)

What are the most cited papers from Medpace (United States)?

The most cited paper from Medpace (United States) is "Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial" (Kishore M. Gadde, David Blair Allison, Donna H. Ryan et al., 2011), with 1,062 citations. Next come "Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol" (1,000) and "Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia" (824).

Most cited papers
#PaperReleasedCitations
1 Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial Kishore M. Gadde, David Blair Allison, Donna H. Ryan et al. · The Lancet Apr 2011 1,062
2 Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol Kausik Kumar Ray, Ulf Landmesser, Lawrence A. Leiter et al. · New England Journal of Medicine Open access 17 Mar 2017 1,000
3 Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia Frederick Johan Raal, David G. Kallend, Kausik Kumar Ray et al. · New England Journal of Medicine Open access 18 Mar 2020 824
4 Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial Stephen A. Harrison, Mustafa Rifaat Bashir, Cynthia D. Guy et al. · The Lancet Nov 2019 794
5 Controlled‐Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP) David Blair Allison, Kishore M. Gadde, William Timothy Garvey et al. · Obesity Open access 3 Nov 2011 725
All 59 most cited papers, with filters and sorting

Which keywords describe research at Medpace (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Immunotherapy, Clinical Trials, Cancer Immunotherapy, Tumor Regression, Lymphoma, CAR T Cells, Chimeric Antigen Receptor and Statins.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Immunotherapy6▲ 11×8 topics
  2. Clinical Trials4▲ 9.5×8 topics
  3. Cancer Immunotherapy4▲ 37×2 topics
  4. Tumor Regression4▲ 49×2 topics
  5. Inflammation3▲ 2.4×28 topics
  6. Lymphoma3▲ 32×2 topics
  7. CAR T Cells3▲ 68×1 topic
  8. Chimeric Antigen Receptor3▲ 68×1 topic
  9. Statins3▲ 69×2 topics
  10. Atherosclerosis3▲ 16×8 topics
  11. C-Reactive Protein3▲ 58×2 topics
  12. Cardiovascular Disease Prevention3▲ 51×3 topics
  13. Cardiovascular Disease3▲ 3.7×13 topics
  14. Cholesterol-lowering3▲ 91×1 topic
  15. Genetic Variants3▲ 24×2 topics
  16. LDL Cholesterol3▲ 123×1 topic
  17. Metabolic Syndrome3▲ 4.9×9 topics
  18. Chemotherapy2▲ 5.2×10 topics
  19. Diabetes2▲ 6.8×9 topics
  20. Tumor Microenvironment2▲ 7.7×4 topics
  21. Cholesterol2▲ 23×3 topics
  22. Obesity2▲ 4.3×9 topics
  23. BRAF Mutation2▲ 39×2 topics
  24. Insulin Resistance2▲ 6.3×5 topics
  25. Targeted Therapy2▲ 13×4 topics
  26. Cancer Therapy2▲ 4.5×11 topics
  27. Genomic Instability2▲ 21×2 topics
  28. Cancer Genomics2▲ 31×1 topic
  29. Differentiated Thyroid Cancer2▲ 55×1 topic
  30. Mutational Signatures2▲ 31×1 topic
  31. Thyroid Carcinoma2▲ 44×2 topics
  32. Thyroid Nodules2▲ 55×1 topic
  33. Pancreatic Cancer1▲ 19×1 topic
  34. Surgical Complications1▲ 26×1 topic
  35. Global Prevalence1▲ 19×1 topic
  36. Glucose Metabolism1▲ 19×1 topic
  37. Lifestyle Intervention1▲ 22×2 topics
  38. Bayesian Methods1▲ 36×2 topics
  39. Dendritic Cells1▲ 21×2 topics
  40. Glycosylation1▲ 16×2 topics

Which research topics does Medpace (United States) publish most on?

By volume in 2022-now: CAR-T cell therapy research, Lipoproteins and Cardiovascular Health, Cancer Genomics and Diagnostics and Thyroid Cancer Diagnosis and Treatment.

  1. 1 CAR-T cell therapy research Oncology 3 works
  2. 2 Lipoproteins and Cardiovascular Health Surgery 3 works
  3. 3 Cancer Genomics and Diagnostics Cancer Research 2 works
  4. 4 Thyroid Cancer Diagnosis and Treatment Endocrinology, Diabetes and Metabolism 2 works
  5. 5 Pancreatic and Hepatic Oncology Research Oncology 1 works
  6. 6 Diabetes, Cardiovascular Risks, and Lipoproteins Endocrinology, Diabetes and Metabolism 1 works
  7. 7 Electrostatic Discharge in Electronics Electrical and Electronic Engineering 1 works
  8. 8 Atherosclerosis and Cardiovascular Diseases Immunology 1 works
  9. 9 High Altitude and Hypoxia Genetics 1 works
  10. 10 Statistical Methods in Clinical Trials Statistics and Probability 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available42.0%not open58.0%

World: 40% of research is openly available.

with international co-authors20.4%domestic only79.6%

World: 18% is written across borders.

How has Medpace (United States)'s research output changed?

Output in 2022-2025 was 29% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Medpace (United States) as a percentage of every work published that year, 0.00027% in 2024.

still counting0.00020%0.00040%0.00060%Medpace (United States)0.00020% in 202519801990200020102020

Fractional works of Medpace (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Cincinnati

All research institutions in Cincinnati

Share Medpace (United States)'s ranking

Medpace (United States) on Science Explorer

A card with Medpace (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Medpace (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.